Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel 5-HT2C receptor ligands in the Pharmacia pipeline

Feb. 5, 2001

Yamanouchi compound stimulates skeletal muscle glucose uptake via effect on GLUT4

Feb. 5, 2001

Compositions and methods of treating obesity claimed by Knoll

Feb. 5, 2001

AOD-9604 safely reduces body weight gain in animal model of obesity

Feb. 5, 2001

Two innovative fertility products launched by Serono in U.S.

Feb. 5, 2001

Venlafaxine for the management of hot flashes in menopausal women

Feb. 2, 2001

Sibutramine maintains significant weight loss over two years in the STORM study

Feb. 2, 2001

Aventis and Novo Nordisk sign license agreement and end Lantus litigation

Feb. 2, 2001

F-12511: a potent ACAT inhibitor with cholesterol-lowering and antiatherosclerotic effects

Feb. 2, 2001

Oral sodium tungstate reduces hyperglycemia and hypertriglyceridemia in ZDF rats

Feb. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...